Lewis William's Form 4 filing
INSMED Inc (INSM) · filed Dec 20, 2024
- Accession no.
- 0001628280-24-052229
- Filed
- Dec 20, 2024
- Trade date
- Dec 19, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.79M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lewis WilliamCIK 0001402051 | Director, Officer (Chair and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | Common Stock | MOption exerciseAcquired | +18,750 | $22.76 | +$426,750 | 403,710 | Direct | |
| Dec 19, 2024 | Common Stock | SSaleDisposed | −13,162 | $69.65F2 | −$916,733.3 | 390,548 | Direct | |
| Dec 19, 2024 | Common Stock | SSaleDisposed | −5,588 | $70.52F3 | −$394,065.76 | 384,960 | Direct | |
| Dec 19, 2024 | Common Stock | MOption exerciseAcquired | +6,830 | $10.85 | +$74,105.5 | 240,754 | Indirect | |
| Dec 19, 2024 | Common Stock | SSaleDisposed | −5,240 | $69.71F4 | −$365,280.4 | 235,514 | Indirect | |
| Dec 19, 2024 | Common Stock | SSaleDisposed | −1,590 | $70.61F5 | −$112,269.9 | 233,924 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | Common Stock | MOption exerciseDisposed | −18,750 | $0.00 | $0 | 112,500 | Direct | |
| Dec 19, 2024 | Common Stock | MOption exerciseDisposed | −6,830 | $0.00 | $0 | 232,290 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 13,162 shares sold at prices ranging from $69.22 to $70.22 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F3
This is the weighted average sales price representing 5,588 shares sold at prices ranging from $70.23 to $70.91 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average sales price representing 5,240 shares sold at prices ranging from $69.28 to $70.27 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F5
This is the weighted average sales price representing 1,590 shares sold at prices ranging from $70.36 to $70.91 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.